Literature DB >> 24652598

[Computer-assisted treatment pathway for schizophrenia. Development and initial experiences].

G Juckel1, K Stahl, C Norra.   

Abstract

Standardization in psychiatry is a developmental process which, following on from psychopathology and nosology is now increasingly affecting the field of treatment. The development of guidelines for the treatment of psychiatric diseases has now become well accepted, although the impact on routine practice is still limited. Treatment pathways bring recommendations from guidelines into a clear and practice-oriented algorithm. The prerequisite for this is the inclusion of all aspects and elements of the treatment as well as all professions involved in the treatment and a valid electronic data processing foundation. Such an approach is presented here with the example of the development and implementation of a clinical pathway for inpatients with schizophrenia. Initial results revealed that patients who received multi-professional treatment within such a clinical pathway, improved better than patients of the control group, as measured by CGI, PANSS and PSP. This shows that introduction of a clinical pathway leads to an improvement of treatment quality. Standardization of psychiatric treatment processes could be highly relevant in respect to the new remuneration system for psychiatry in Germany.

Entities:  

Mesh:

Year:  2015        PMID: 24652598     DOI: 10.1007/s00115-013-3818-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

1.  Do clinical pathways really improve clinical performance in mental health settings?

Authors:  Brett Emmerson; Aaron Frost; Lisa Fawcett; Emma Ballantyne; Warren Ward; Stan Catts
Journal:  Australas Psychiatry       Date:  2006-12       Impact factor: 1.369

Review 2.  Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

Authors:  Peter J Weiden; Peter F Buckley
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

3.  The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.

Authors:  J A Chiles; A L Miller; M L Crismon; A J Rush; A S Krasnoff; S S Shon
Journal:  Psychiatr Serv       Date:  1999-01       Impact factor: 3.084

4.  The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.

Authors:  A L Miller; J A Chiles; J K Chiles; M L Crismon; A J Rush; S P Shon
Journal:  J Clin Psychiatry       Date:  1999-10       Impact factor: 4.384

5.  [Guideline compliance in the treatment of schizophrenic patients. Introduction of a computer-assisted treatment pathway].

Authors:  F Godemann; K Blittersdorf; M Poschenrieder; H Klimitz; I Hauth; H Gutzmann
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

6.  Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.

Authors:  Michael Bauer; Andrea Pfennig; Michael Linden; Michael N Smolka; Peter Neu; Mazda Adli
Journal:  J Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.153

7.  Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.

Authors:  Peter J Weiden
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

8.  The effects of a clinical care pathway for schizophrenia: a before and after study in 114 patients.

Authors:  Bruno Steinacher; Lieselotte Mausolff; Burkhard Gusy
Journal:  Dtsch Arztebl Int       Date:  2012-11-16       Impact factor: 5.594

9.  Sensation-seeking and emotional disturbances in depression: relationships and evolution.

Authors:  S Carton; P Morand; C Bungenera; R Jouvent
Journal:  J Affect Disord       Date:  1995-06-08       Impact factor: 4.839

10.  The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Authors:  Troy A Moore; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Susan M Essock; Molly Finnerty; Stephen R Marder; Del D Miller; Joseph P McEvoy; Delbert G Robinson; Nina R Schooler; Steven P Shon; T Scott Stroup; Alexander L Miller
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.